Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
posted on 2021-03-25, 03:08authored byCamille Vong, Martin Boucher, Steve Riley, Lutz Harnisch
Article
full text
The article associated with this page has been accepted for
online publication and is in the final stages of production. The link to the
full text will be made available on this page in the next few days.
The above infographic represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).